Yıl: 2015 Cilt: 2 Sayı: 3 Sayfa Aralığı: 203 - 209 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals

Öz:
OBJECTIVE: Toxoplasma gondii, Rubella, Cytomegalovirus and Herpes simplex viruses are microorganisms that cause congenital infections and they are called briefly as TORCH. There is an ongoing argument for the screening of reproductive age women due to the high cost of tests. For a test to be used in screening, prevalence of disease in this population should be known. The aim of this study was to investigate TORCH seroprevalence among women attending a teaching hospital in Istanbul. METHODS: A total of 1101 patients attending outpatient clinic of Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals between September 2013 to January 2015 and their laboratory data were evaluated retrospectively. We investigated Ig G and M seropositivity rates against TORCH. RESULTS: The age of the patients ranged between 17 47 years with a mean age of 30.3±5.8 years. Pregnant population had 99.5% anti-CMV Ig G (+), 94.2% anti-Rubella Ig G (+), 31% anti-Toxoplasma Ig G (+). Seroprevalence for Anti IgM was 0.5% for CMV, 0.2% for rubella. CONCLUSION: The screening for Toxoplasma gondii may be suggested since the prevalence is not high in our population. The screening of CMV is not meaningful, due to high seroprevalence. Although seroprevalence of rubella is also high, it may be suggested for preconception vaccination especially in women above 20 years of age born prior to National Vaccination Programme.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Karacan M, Batukan M, Cebi Z, Berberoglugil M, Levent S, Kır M, et al. Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status. Arch Gynecol Obstet 2014;290:1115–20. 2. Yamamoto R, Ishii K, Shimada M, Hayashi S, Hidaka N, Nakayama M, et al. Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction. J Obstet Gynaecol Res 2013;39:653–7. 3. Patel KK, Shrivastava G, Bhatambare G, Bajpai T. Antenatal detection of Ig M and Ig G antibodies to Toxoplasma gondii in a hospital from central India. Int J Health Sys and Disaster Man 2014;2:133–5. 4. Feldman DM, Timms D, Borgida AF. Toxoplasmosis, parvovirus, and cytomegalovirus in pregnancy. Clin Lab Med 2010;30:709– 20. 5. Gibson CS, MacLennan AH, Goldwater PN, Haan EA, Priest K, Dekker GA; South Australian Cerebral Palsy Research Group. Neurotropic viruses and cerebral palsy: population based case-control study. BMJ 2006;332:76–80. 6. Jahromi AS, Kazemi A, Manshoori G, Madani A, Moosavy SH, Seddigh B. Seroprevalence of Rubella virüs in women with spontaneus abortion. Am J Inf Dis 2011;7:16–9. 7. Duran B, Toktamis A, Erden O, Demirel Y, Mamik BA, Cetin M. Doğum öncesi bakımda tartışmalı bir konu: TORCH taraması. C.Ü. Tıp Fakültesi Derg 2002;24:185–90. 8. Abdel-Fattah SA, Bhat A, Illanes S, Bartha JL, Carrington D. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom. Prenat Diagn 2005;25:1028–31. 9. Chaudhry SA, Gad N, Koren G. Toxoplasmosis and pregnancy. Can Fam Physician 2014;60:334–6. 10. Remington JS, McLeod R, Wilson CB, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado YA eds. Infectious Diseases of the Fetus and Newborn Infant. Elsevier-Saunders, 7th ed, Philadelphia, PA, 2011. p. 918–1041. 11. Karabulut A, Polat Y, Türk M, Isik Balci Y. Evaluation of rubella, toxoplasma gondii and cytomegalo virus seroprevalemces among pregnant women in Denizli province. Turk J Med Sci 2011;41:159–64. 12. Dogan K, Kafkaslı A, Karaman U, Atambay M, Karaoğlu L, Colak C. The rates of seropositivity and seroconversion of toxoplasma infection in pregnant women. Mikrobiyol Bul 2012;46:290–4. 13. Tekay F, Ozbek E. The seroprevalence of Toxoplasma gondii in women from Sanliurfa, a province with a high raw meatball consumption. Turkiye Parazitol Derg 2007;31:176–9. 14. Ocak S, Zeteroglu S, Ozer C, Dolapcioglu K, Gungoren A. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey. Scand J Infect Dis 2007;39:231–4.
  • 15. Kolgelier S, Demiraslan H, Kataş B, Guler D. Seroprevalence of Toxoplasma gondii in Pregnant Women. Dicle Tıp Derg 2009;36:170–2.
  • 16. Tamer GS, Dundar D, Caliskan E. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey. Clin Invest Med 2009;32:43–7.
  • 17. Inci A, Yener C, Güven D. The investigation of toxoplasma, rubella and cytomegalovirus seroprevalancies in pregnant women in a state hospital. Pam Med J 2014;7:143–6.
  • 18. Varol FG, Sayin NC, Soysuren S. Seroprevalance of toxoplasma gondii antibodies in antenatal population of Trakya region. J Turk Soc Obstet Gynecol 2011;8:93–9.
  • 19. Yilmazer M, Altindis M, Cevrioglu S, Fenkci V, Aktepe O, Sirthan E. Toxoplasma, Cytomegalovirus, Rubella, Hepatitis B and Hepatitis C Seropositivity Rates in Pregnant Women Who Live in Afyon Region. Kocatepe Tıp Derg 2004;2:49–53.
  • 20. Yigit N, Aktaş AE, Uslu H, Aydın F, Babacan M. Atatürk Üniversitesi Tıp Fakültesi Mikrobiyoloji Laboratuvarına gelen toxoplasmosis şüpheli hasta serumlarında Toxoplasma gondii antikorlarının araştı- rılması. Türkiye Parazitol Derg 2000;24:22–4.
  • 21. Gul K, Dağ MN, Suay A, Mete M, Mete Ö. D.Ü. Tıp Fakültesinin değişik bölümlerine başvuran ve Toxoplasma ön tanısı konmuş hastalarda Toxoplasma antikorlarının dağılımı. Türkiye Parazitol Derg 1994;18:394–7.
  • 22. Asci Z, Seyrek A, Kizirgil A, Doymaz MZ, Yılmaz M. Toxoplasma şüpheli hasta serumlarında anti-Toxoplasma gondii IgG ve IgM antikorlarının araştırılması. Türkiye Parazitol Dergisi 1997;21:245–7.
  • 23. Efe S, Kurdoğlu Z, Korkmaz G. Van yöresindeki gebelerde Sitomegalovirüs, Rubella ve Toksoplazma antikorlarının seroprevalansı. Van Tıp Derg 2009;16:6–9.
  • 24. Polat E, Aslan M, Isenkul R, Aygun G, Aksin N, Cepni I, et al. Gebe kadınlarda toxoplasma gondii Ig M ve Ig G antikorlarının ELISA yöntemi ile araştırılması. T Parazitol Derg 2002; 26:350– 1.
  • 25. Selek MB, Bektöre B, Baylan O, Özyurt M. Serological Investigation of Toxoplasma gondii on Pregnant Women and Toxoplasmosis Suspected Patients Between 2012-2014 Years on a Tertiary Training Hospital. Turkiye Parazitol Derg 2015;39:200–4.
  • 26. Uyar Y, Balci A, Akcali A, Cabar C. Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey. New Microbiol 2008;31:451–5.
  • 27. Karakas A, Türker T, Arslan E, Turhan V. Investigation of Rubella susceptibility rate among women of chlidbearing age in a private medical center, Van province, Turkey. Türk Hijyen ve Deneysel Biyoloji Dergisi 2010;67:179–84.
  • 28. Tekin A, Deveci Ö, Yula E. The seroprevalence of antibodies against Toxoplasma gondii and Rubella virus among childbearing age women in Mardin province. J Clin Exp Invest 2010;1:81–5.
  • 29. Collinet P, Subtil D, Houfflin-Debarge V, Kacet N, Dewilde A, Puech F. Routine CMV screening during pregnancy. Eur J Obstet Gynecol Reprod Biol 2004;114:3–11.
  • 30. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007;17:253–76.
  • 31. Dollard SC, Staras SA, Amin MM, Schmid DS, Cannon MJ. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clin Vaccine Immunol 2011;18:1895–9.
  • 32. Oruc AS, Celen S, Citil A, Saygan S, Unlu S, Danisman N. Screening of cytomegalovirus seroprevalence among pregnant women in Ankara, Turkey: A controversy in prenatal care. Afr J MicrobiolRes 2011;5:5304–7.
APA NUMAN O, VURAL F, AKA N, ALPAY M, COŞKUN ERTÜRK A (2015). TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals. , 203 - 209.
Chicago NUMAN Onur,VURAL Fisun,AKA Nurettin,ALPAY Murat,COŞKUN ERTÜRK Ayşe Deniz TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals. (2015): 203 - 209.
MLA NUMAN Onur,VURAL Fisun,AKA Nurettin,ALPAY Murat,COŞKUN ERTÜRK Ayşe Deniz TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals. , 2015, ss.203 - 209.
AMA NUMAN O,VURAL F,AKA N,ALPAY M,COŞKUN ERTÜRK A TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals. . 2015; 203 - 209.
Vancouver NUMAN O,VURAL F,AKA N,ALPAY M,COŞKUN ERTÜRK A TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals. . 2015; 203 - 209.
IEEE NUMAN O,VURAL F,AKA N,ALPAY M,COŞKUN ERTÜRK A "TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals." , ss.203 - 209, 2015.
ISNAD NUMAN, Onur vd. "TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals". (2015), 203-209.
APA NUMAN O, VURAL F, AKA N, ALPAY M, COŞKUN ERTÜRK A (2015). TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals. İstanbul Kuzey Klinikleri, 2(3), 203 - 209.
Chicago NUMAN Onur,VURAL Fisun,AKA Nurettin,ALPAY Murat,COŞKUN ERTÜRK Ayşe Deniz TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals. İstanbul Kuzey Klinikleri 2, no.3 (2015): 203 - 209.
MLA NUMAN Onur,VURAL Fisun,AKA Nurettin,ALPAY Murat,COŞKUN ERTÜRK Ayşe Deniz TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals. İstanbul Kuzey Klinikleri, vol.2, no.3, 2015, ss.203 - 209.
AMA NUMAN O,VURAL F,AKA N,ALPAY M,COŞKUN ERTÜRK A TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals. İstanbul Kuzey Klinikleri. 2015; 2(3): 203 - 209.
Vancouver NUMAN O,VURAL F,AKA N,ALPAY M,COŞKUN ERTÜRK A TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals. İstanbul Kuzey Klinikleri. 2015; 2(3): 203 - 209.
IEEE NUMAN O,VURAL F,AKA N,ALPAY M,COŞKUN ERTÜRK A "TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals." İstanbul Kuzey Klinikleri, 2, ss.203 - 209, 2015.
ISNAD NUMAN, Onur vd. "TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals". İstanbul Kuzey Klinikleri 2/3 (2015), 203-209.